Top Pharmaceuticals companies in Spain by Cash and Short-Term Investments

This ranking features the top 13 Pharmaceuticals companies in Spain ranked by Cash and Short-Term Investments, totalling a Cash and Short-Term Investments of USD 1.49 B, for January 16, 2025.
#
Name
Cash and Short-Term Investments
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 584.52 M
Dec. 31, 2023 USD 9.29 3.24%

Spain

2
USD 428.35 M
Dec. 31, 2023 USD 8.60 3.71%

Spain

3
USD 179.43 M
Dec. 31, 2023 USD 77.86 1.89%

Spain

4
USD 56.56 M
Dec. 31, 2023 USD 33.70 0.30%

Spain

5
USD 52.71 M
Dec. 31, 2023 USD 3.46 -1.45%

Spain

6
USD 46.55 M
Dec. 31, 2023 USD 3.66 0.89%

Spain

7
USD 43.21 M
Dec. 31, 2023 USD 3.65 0.32%

Spain

8
USD 29.91 M
Dec. 31, 2023 USD 1.76 1.20%

Spain

9
USD 27.95 M
Dec. 31, 2023 USD 59.78 -0.59%

Spain

10
USD 14.62 M
Dec. 31, 2023 USD 9.87 0.82%

Spain

11
USD 13.53 M
Dec. 31, 2023 USD 1.51 -0.07%

Spain

12
USD 7.02 M
Dec. 31, 2023 USD 2.59 -1.36%

Spain

13
USD 3.08 M
Dec. 31, 2023 USD 1.80 0.04%

Spain

Frequently Asked Questions
  • Which Pharmaceuticals company in Spain has the highest Cash and Short-Term Investments ?

    The Pharmaceuticals company in Spain with the highest Cash and Short-Term Investments is Grifols, S.A. (MCE: GRF.MC) at USD 584.52 M.

  • Which Pharmaceuticals company in Spain has the lowest Cash and Short-Term Investments ?

    The Pharmaceuticals company in Spain with the lowest Cash and Short-Term Investments is Pangaea Oncology, S.A. (MCE: PANG.MC) at USD 3.08 M.